Preoperative Hypofractionated RT + Immunotherapy & Surgery for Retroperitoneal Sarcoma (FUSION-02)

Clinical trial NCT07396116 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07396116
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Soft Tissue Sarcoma (STS)Retroperitoneal Sarcoma Immunotherapy Radiotherapy Side Effect Ultra-hypofractionated Radiotherapy

Start date: 2026-02-12
Primary completion: 2028-12-31
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.